Michaela Liedtke, MD
Michaela Liedtke, MD, is an Associate Professor of Medicine at the Stanford University School of Medicine, where she also serves as the Medical Director of the Leukemia inpatient service, Co-Director of the Stanford Adolescent and Young Adult Cancer program, and Co-Director of the Stanford Amyloid Center.
Dr. Liedtke received her medical degree from Hanover Medical School in Germany, and completed her residency in internal medicine at Albert Einstein College of Medicine and a fellowship in hematology and oncology at Memorial Sloan-Kettering Cancer Center and Stanford University.
She specializes in research and treatment of multiple myeloma/amyloidosis and acute lymphoblastic leukemia, with particular interest in ALL in adolescents and young adults and CAR-T cell technology, and has contributed to numerous clinical and translational studies in her field.
Dr. Liedtke is an active member of the American Society of Hematology and the American Society of Clinical Oncology, serves on the Leukemia committee for the Southwest Oncology Group, and is a member of the NCCN Multiple Myeloma and AL amyloidosis Panel.
Representative Publications:
Reversible High-Output Cardiac Failure, an Unusual Marker of Disease Status in Multiple Myeloma.
Heart Transplantation and Cardiac Amyloidosis: Approach to Screening and Novel Management Strategies.
Lenalidomide, Melphalan and Dexamethasone in a Population of Patients With Immunoglobulin Light Chain Amyloidosis With High Rates of Advanced Cardiac Involvement.
Implantable Cardioverter-Defibrillator Placement in Patients With Cardiac Amyloidosis.
Outcomes After Heart Transplantation for Amyloid Cardiomyopathy in the Modern Era.
